Esperion Therapeutics, Inc. · NASDAQ:ESPR
Thompson John Craig received 79,873 Esperion Therapeutics, Inc. shares as an award (Form 4)
Traded May 28, 2026 · Filed Jun 1, 2026
On May 28, 2026, Thompson John Craig (Director) received 79,873 Esperion Therapeutics, Inc. shares as an award, leaving 79,873 shares. Filed Jun 1, 2026 (Form 4).
- Awarded
- 79,873 shares
- Holding after
- 79,873 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 28, 2026 | Common Stock | Award | 79,873 | 79,873 | Direct |
Source
Related
- Esperion Therapeutics, Inc.
- Thompson John Craig
- Esperion Therapeutics, Inc. shareholders
- Form 4 · Thompson John Craig · Jul 13, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026